SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-15-014912
Filing Date
2015-03-10
Accepted
2015-03-09 17:53:11
Documents
1
Group Members
BEN T. MORRISDON A. SANDERSDONALD V. WEIRJAMES C. GALELIFE SCIENCES OPPORTUNITIES FUND (INSTITUTIONAL) II, L.P.SIGNET HEALTHCARE PARTNERS, LLCSMW INVESTMENTS I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v403962_sc13da.htm SC 13D/A 163027
  Complete submission text file 0001144204-15-014912.txt   164981
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 6096971441
IGI LABORATORIES, INC (Subject) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-34057 | Film No.: 15686397
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Business Address 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019 212-419-3900
LIFE SCIENCES OPPORTUNITIES FUND II LP (Filed by) CIK: 0001269415 (see all company filings)

IRS No.: 571190948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A